NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
TrumpTariffTradeFebruaryStrikesAnnounceLaunchNewsPricesMajorMilitaryHongKongCourtDigestSundayTimelineChinaTechSafetyGlobalMarketIranianTest
TrumpTariffTradeFebruaryStrikesAnnounceLaunchNewsPricesMajorMilitaryHongKongCourtDigestSundayTimelineChinaTechSafetyGlobalMarketIranianTest
All Articles
STAT News
Clustered Story
Published 7 days ago

STAT+: Exit of CDC’s acting director highlights agency’s lack of leader

STAT News · Feb 15, 2026 · Collected from RSS

Summary

The lack of a Senate-confirmed leader is deepening the turmoil at the CDC.

Full Article

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on Signal at hbranswell.01.For 28 days last summer, the Centers for Disease Control and Prevention had a director who had been confirmed by the Senate. But in less time than it took Susan Monarez to get approved, she was fired for not kowtowing to her boss, Robert F. Kennedy Jr., over vaccination policy. It’s starting to look increasingly possible that that less than month-long stretch may be the only period in the second Trump administration when the agency has a full-time director, according to several public health experts who follow the agency closely. President Trump hasn’t nominated a new director to replace Monarez, and a White House spokesman didn’t respond to a request for comment. “I think there’s a high likelihood that the CDC will not have a presidentially appointed and a confirmed director in [the remainder of] this administration,” Samuel Bagenstos, a professor of law and social policy at the University of Michigan, told STAT. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe


Share this story

Read Original at STAT News

Related Articles

Wired1 day ago
The CDC Has a Leadership Crisis

A 2023 law championed by Republicans requires the CDC have a director confirmed by the Senate. For months, though, it's had only acting directors—and the White House won't say when that will change.

STAT News1 day ago
STAT+: Nature Medicine to investigate study that found cancer treatment is better in morning

Nature Medicine starts an investigation into inconsistencies in a study that found it was better to have immunotherapy in the morning.

STAT News1 day ago
STAT+: DOJ, Ohio attorney general accuse OhioHealth of driving up prices, crowding out competition

Regulators say Ohio hospital system made it difficult for health insurers to offer cheaper plans.

STAT News2 days ago
STAT+: Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

STAT News2 days ago
STAT+: Element Biosciences launches table-top sequencer capable of $100 genome

And other biotech news brought to you by The Readout newsletter

STAT News2 days ago
STAT+: Pharmalittle: We’re reading about an FDA official’s speech, a Grail cancer blood test, and much more

The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV